0,994  0,001  Transcription factor NF kappa B inhibitor
0,991  0,000  Chemopreventive
0,984  0,001  Antithrombotic
0,974  0,002  Chemoprotective
0,947  0,001  Cytotoxic
0,945  0,001  Antihypoxic
0,943  0,002  NOS2 expression inhibitor
0,941  0,005  Apoptosis agonist
0,936  0,003  Antihypercholesterolemic
0,933  0,002  Cholesterol antagonist
0,933  0,002  Caspase 9 stimulant
0,930  0,005  Antiinflammatory
0,904  0,004  TNF expression inhibitor
0,872  0,002  Monophenol monooxygenase inhibitor
0,855  0,001  AMP-activated protein kinase stimulant
0,852  0,003  Proliferative diseases treatment
0,850  0,003  Immunostimulant
0,837  0,005  Respiratory analeptic
0,832  0,004  Nitric oxide antagonist
0,831  0,005  Cyclophilin D inhibitor
0,831  0,005  Antidiabetic
0,827  0,003  Angiogenesis stimulant
0,810  0,008  Teratogen
0,797  0,004  Apoptosis antagonist
0,801  0,008  Antineoplastic (lung cancer)
0,796  0,009  Embryotoxic
0,776  0,004  Caspase 3 stimulant
0,781  0,011  Antineoplastic (breast cancer)
0,773  0,004  Hepatic disorders treatment
0,776  0,007  Antileukemic
0,771  0,005  Analeptic
0,770  0,005  Antioxidant
0,745  0,006  Sensitization
0,742  0,004  Antiparasitic
0,739  0,006  Antibacterial
0,734  0,001  Protein kinase stimulant
0,725  0,004  Hepatoprotectant
0,724  0,003  Antihelmintic
0,725  0,005  Hypoglycemic
0,717  0,008  Mutagenic
0,710  0,003  Hair growth stimulant
0,705  0,002  Antifungal enhancer
0,701  0,005  Vascular (periferal) disease treatment
0,695  0,005  UGT1A1 substrate
0,688  0,005  Cardioprotectant
0,681  0,007  Antineoplastic (melanoma)
0,670  0,002  Gastrin inhibitor
0,670  0,013  Carcinogenic
0,655  0,012  Antineoplastic (ovarian cancer)
0,637  0,006  Tumour necrosis factor alpha release inhibitor
0,632  0,005  Myocardial infarction treatment
0,641  0,014  Prostate cancer treatment
0,643  0,019  Antineoplastic (colorectal cancer)
0,618  0,013  5 Hydroxytryptamine release stimulant
0,614  0,009  Lipoprotein disorders treatment
0,613  0,010  Antipruritic, allergic
0,608  0,012  Immunosuppressant
0,593  0,002  Cyclooxygenase 3 inhibitor
0,599  0,011  Antineoplastic (pancreatic cancer)
0,590  0,006  Antineoplastic (lymphoma)
0,586  0,004  Platelet adhesion inhibitor
0,590  0,009  Antineoplastic (multiple myeloma)
0,590  0,012  NOS3 expression inhibitor
0,579  0,004  Melanin inhibitor
0,574  0,003  Expectorant
0,594  0,023  Antineoplastic (colon cancer)
0,576  0,005  Antihypertriglyceridemic
0,574  0,005  Antineoplastic (liver cancer)
0,575  0,010  Antifungal
0,565  0,003  Histone deacetylase stimulant
0,565  0,003  Histone deacetylase SIRT1 stimulant
0,571  0,011  Antidiabetic (type 2)
0,556  0,005  Transcription factor STAT3 inhibitor
0,552  0,001  Glycine receptor antagonist
0,563  0,014  AR expression inhibitor
0,546  0,005  ICAM1 expression inhibitor
0,545  0,008  Antineoplastic (endocrine cancer)
0,515  0,009  UGT2B4 substrate
0,516  0,011  Vasodilator
0,518  0,017  Antineoplastic (brain cancer)
0,504  0,006  Interferon gamma antagonist
0,526  0,032  Antiobesity
0,499  0,011  Antineoplastic enhancer
0,492  0,007  Skin whitener
0,495  0,012  UDP-glucuronosyltransferase substrate
0,507  0,027  Stroke treatment
0,488  0,009  Transcription factor STAT inhibitor
0,491  0,013  Hypolipemic
0,483  0,009  Antiulcerative
0,461  0,001  Na+ K+ transporting ATPase inhibitor
0,466  0,009  Antiviral (Herpes)
0,473  0,015  DNA synthesis inhibitor
0,485  0,030  Bone diseases treatment
0,471  0,023  UGT1A9 substrate
0,466  0,025  Antiosteoporotic
0,459  0,020  Free radical scavenger
0,475  0,038  Atherosclerosis treatment
0,471  0,035  Vasodilator, peripheral
0,442  0,013  Wound healing agent
0,432  0,007  Antiviral (Influenza)
0,445  0,023  Antiprotozoal (Leishmania)
0,430  0,009  UGT2B7 substrate
0,425  0,004  Antihemorrhagic
0,424  0,005  Antiviral (Influenza A)
0,424  0,008  Antipruritic, non-allergic
0,446  0,029  Antineoplastic (cervical cancer)
0,443  0,029  Antineoplastic (glioma)
0,422  0,028  Antineoplastic (non-small cell lung cancer)
0,422  0,030  Cytostatic
0,396  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,396  0,009  Amylase inhibitor
0,400  0,017  Sodium/bile acid cotransporter inhibitor
0,405  0,023  Antineoplastic (renal cancer)
0,411  0,038  Spasmolytic
0,388  0,031  Antiamyloidogenic
0,364  0,008  Neurotrophic factor enhancer
0,380  0,034  Interleukin 2 agonist
0,358  0,015  Antineoplastic (squamous cell carcinoma)
0,361  0,020  P-glycoprotein inhibitor
0,348  0,009  Insulin sensitizer
0,345  0,013  Lipid peroxidase inhibitor
0,342  0,013  Antineoplastic (gastric cancer)
0,359  0,034  Antineoplastic (glioblastoma multiforme)
0,328  0,009  Cholesterol synthesis inhibitor
0,364  0,045  Metabolic disease treatment
0,336  0,020  Contraceptive
0,317  0,004  Transcription factor NF kappa B stimulant
0,315  0,006  Dementia treatment
0,325  0,017  Lipocortins synthesis antagonist
0,313  0,006  Vascular dementia treatment
0,337  0,033  Antineoplastic (lymphocytic leukemia)
0,313  0,009  Antineoplastic antibiotic
0,320  0,019  Antiacne
0,317  0,021  Thrombolytic
0,341  0,053  CYP2C19 substrate
0,284  0,006  Selectin antagonist
0,307  0,031  Antiviral (HIV)
0,313  0,036  Antineoplastic (sarcoma)
0,322  0,049  DNA damaging
0,320  0,050  Antipyretic
0,288  0,020  Sepsis treatment
0,279  0,013  DNA polymerase I inhibitor
0,274  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,269  0,013  Aldose reductase substrate
0,278  0,025  Antineoplastic (carcinoma)
0,301  0,052  Platelet antagonist
0,273  0,025  Protein-tyrosine phosphatase inhibitor
0,257  0,010  Farnesoid X receptor antagonist
0,256  0,009  Anticataract
0,263  0,017  Insulin secretagoues
0,278  0,034  Peptidyltransferase inhibitor
0,307  0,065  Antineoplastic (osteosarcoma)
0,301  0,065  Hypoxia-inducible factor 1 alpha inhibitor
0,273  0,038  RNA-directed DNA polymerase inhibitor
0,269  0,036  Non-steroidal antiinflammatory agent
0,235  0,010  Antibiotic
0,270  0,045  Septic shock treatment
0,248  0,024  Interleukin 6 antagonist
0,234  0,019  Alkylator
0,230  0,021  Antiviral (Hepatitis B)
0,341  0,133  Alzheimer's disease treatment
0,216  0,014  Choleretic
0,226  0,028  UGT2B9 substrate
0,260  0,069  Antidiabetic symptomatic
0,208  0,019  Retinoprotector
0,260  0,072  Interleukin agonist
0,223  0,035  Liver fibrosis treatment
0,211  0,024  Topoisomerase I inhibitor
0,277  0,095  Immunomodulator
0,207  0,026  Arachidonic acid antagonist
0,203  0,024  Antitussive
0,229  0,055  Abortion inducer
0,194  0,023  Antifungal (Cryptococcus)
0,203  0,034  ATPase inhibitor
0,229  0,060  VCAM1 expression inhibitor
0,194  0,030  Psychosexual dysfunction treatment
0,180  0,019  Antineoplastic, alkylator
0,169  0,013  Toll-Like receptor 4 antagonist
0,200  0,045  Prostate disorders treatment
0,208  0,054  Antiviral (Hepatitis)
0,153  0,002  Cholesterol absorption inhibitor
0,244  0,096  Radioprotector
0,174  0,027  Beta amyloid protein antagonist
0,176  0,030  Adenylate cyclase stimulant
0,187  0,042  Antidiarrheal
0,294  0,157  Antiarthritic
0,162  0,032  Microtubule formation inhibitor
0,166  0,037  Cell adhesion inhibitor
0,143  0,019  Thioredoxin inhibitor
0,197  0,074  Sedative
0,251  0,131  CYP3A4 substrate
0,154  0,038  Growth stimulant
0,148  0,034  Alcohol dehydrogenase substrate
0,241  0,129  Antiallergic
0,137  0,026  Anabolic
0,142  0,037  Mucolytic
0,114  0,011  Phosphorylase inhibitor
0,130  0,027  Topoisomerase II alpha inhibitor
0,112  0,010  Antibiotic Glycopeptide-like
0,141  0,042  Contraceptive female
0,111  0,019  Antiviral (Dengue virus)
0,113  0,022  CDC25A inhibitor
0,156  0,067  NOS3 expression enhancer
0,128  0,040  Antiinfertility, female
0,112  0,026  ATPase (Vacuolar H+) inhibitor
0,219  0,134  Antimycobacterial
0,135  0,052  CC chemokine 6 receptor antagonist
0,091  0,008  Lipocortins synthesis agonist
0,089  0,008  Acetyl-CoA transferase 2 inhibitor
0,095  0,014  Protein 50S ribosomal subunit inhibitor
0,130  0,060  Topoisomerase II inhibitor
0,088  0,018  Acetyl-CoA transferase inhibitor
0,120  0,050  Neutropenia treatment
0,166  0,098  Anesthetic general
0,101  0,033  Antiprotozoal activity enhancer
0,143  0,076  Antidiabetic (type 1)
0,158  0,091  Phospholipase C inhibitor
0,067  0,001  Telomerase stimulant
0,085  0,018  Nitric oxide donor
0,076  0,013  Alpha-mannosidase inhibitor
0,229  0,169  CYP2C9 substrate
0,148  0,089  Antihelmintic (Nematodes)
0,066  0,007  Antibiotic Aminoglycoside-like
0,107  0,048  UGT2B11 substrate
0,091  0,033  Lipase inhibitor
0,128  0,075  Liver cirrhosis treatment
0,237  0,186  CYP2C19 inhibitor
0,150  0,100  UGT2B10 substrate
0,054  0,007  Protein 30S ribosomal subunit inhibitor
0,107  0,061  HDL-cholesterol increasing
0,097  0,055  Bile acid receptor antagonist
0,133  0,091  Hemostatic
0,122  0,082  Vanilloid 1 agonist
0,080  0,042  Antitreponemal
0,070  0,032  Antimycoplasmal
0,147  0,110  Diabetic nephropathy treatment
0,088  0,052  Antispirochetal
0,056  0,020  Microtubule stabilization
0,160  0,126  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,190  0,158  Antipsoriatic
0,053  0,023  Mannosidase inhibitor
0,079  0,049  Narcotic antagonist
0,064  0,036  Heme oxygenase stimulant
0,069  0,042  Andropause treatment
0,085  0,059  Antineoplastic alkaloid
0,070  0,046  Anticholelithogenic
0,096  0,075  Skin irritative effect
0,089  0,068  Antiviral (Rhinovirus)
0,044  0,024  Acetyl-CoA transferase 1 inhibitor
0,086  0,066  Actinic keratosis treatment
0,033  0,014  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,027  0,009  Corticosteroid-like
0,037  0,019  Squalene synthetase inhibitor
0,035  0,018  RNA-directed RNA polymerase stimulant
0,031  0,014  1,3-Beta-glucan synthase inhibitor
0,051  0,036  Glucose-6-phosphate translocase inhibitor
0,035  0,023  HMG CoA reductase inhibitor
0,027  0,016  Toll-Like receptor 4 agonist
0,046  0,038  Estrogen agonist
0,036  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,120  0,112  Eye irritation, high
0,011  0,010  Glucocorticoid agonist
0,121  0,120  Antinephritic
0,035  0,034  Glucose-6-phosphate dehydrogenase inhibitor

